Cell uptake of paclitaxel solid lipid nanoparticles modified by cell-penetrating peptides in A549 cells

Pharmazie

Volumn 68, Issue 1, 2013, Pages 47-53

  Zhang, Yin Long ^a   Zhang, Zhen Hai ^a   Jiang, Tian Yue ^a   Ayman Waddad, ^a   Jing Li, ^a   Lv, Hui Xia ^a   Zhou, Jian Ping ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CELL PENETRATING PEPTIDE; COUMARIN; DRUG CARRIER; OCTAARGININE; PACLITAXEL; SOLID LIPID NANOPARTICLE; STEARIC ACID; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; COUMARIN DERIVATIVE; LIPID; NANOPARTICLE; PEPTIDE;

ARTICLE; CANCER CELL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DISPERSION; DRUG RELEASE; DRUG UPTAKE; HUMAN; HUMAN CELL; INCUBATION TIME; LOADING TEST; MORPHOLOGY; PARTICLE SIZE; PRODUCTIVITY; ZETA POTENTIAL; ATOMIC FORCE MICROSCOPY; CELL SURVIVAL; CHEMISTRY; DIALYSIS; DOSE RESPONSE; DRUG EFFECT; FLUORESCENCE MICROSCOPY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL LINE, TUMOR; CELL SURVIVAL; COUMARINS; DIALYSIS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LIPIDS; MICROSCOPY, ATOMIC FORCE; MICROSCOPY, FLUORESCENCE; NANOPARTICLES; PACLITAXEL; PARTICLE SIZE; PEPTIDES;

MLCS; MLOWN;

EID: 84875781324     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2013.2071     Document Type: Article

References (38)

1. Aroui S, Brahim S, Waard MD, KenaniA(2010a) Cytotoxicity, intracellular distribution and uptake of doxorubicin and doxorubicin coupled to cell-penetrating peptides in different cell lines: a comparative study. Biochem Biophys Res Commun 391: 419-425.
2. Aroui S, Mili D, Brahim S, De Waard M, Kenani A (2010b) Doxorubicin coupled to penetratin promotes apoptosis in CHO cells by a mechanism involving c-Jun NH2-terminal kinase. Biochem Biophys Res Commun 396: 908-914.
3. Barnes MP, Shen WC (2009) Disulfide and thioether linked cytochrome c-oligoarginine conjugates in HeLa cells. Int J Pharm 369: 79-84.
4. Castro GA, Coelho ALLR, Oliveira CA, Mahecha GAB, Oréfice RL, Ferreira LAM (2009) Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles. Int J Pharm 381: 77-83.
5. Castro GA, Orefice RL, Vilela JM, Andrade MS, Ferreira LA (2007) Development of a new solid lipid nanoparticle formulation containing retinoic acid for topical treatment of acne. J Microencapsul 24: 395-407.
6. Costa P, Sousa Lobo JM (2001) Modeling and comparison of dissolution profiles. Eur J Pharm Sci 13: 123-133.
7. Deshayes S, Morris M, Heitz F, Divita G (2008) Delivery of proteins and nucleic acids using a non-covalent peptide-based strategy.AdvDrug Deliv Rev 60: 537-547.
8. Endoh T, Ohtsuki T (2009). Cellular siRNA delivery using cell-penetrating peptides modified for endosomal escape. Adv Drug Deliv Rev 61: 704-709.
9. Furukawa R, Yamada Y, Takenaga M, Igarashi R, Harashima H (2011) Octaarginine-modified liposomes enhance the anti-oxidant effect of Lecithinized superoxide dismutase by increasing its cellular uptake. Biochem Biophys Res Commun 404: 796-801.
10. Futaki S, Ohashi W, Suzuki T, Niwa M, Tanaka S, Ueda K, Harashima H, Sugiura Y (2001) Stearylated arginine-rich peptides: a new class of transfection systems. Bioconjug Chem 12: 1005-1011.
11. Gualbert J, Shahgaldian P, Coleman AW(2003) Interactions of amphiphilic calix[4]arene-based Solid Lipid Nanoparticles with bovine serum albumin. Int J Pharm 257: 69-73.
12. Homhuan A, Kogure K, Nakamura T, Shastri N, Harashima H (2009) Enhanced antigen presentation and CTL activity by transduction of mature rather than immature dendritic cells with octaarginine-modified liposomes. J Control Release 136: 79-85.
13. Katayama S, Hirose H, Takayama K, Nakase I, Futaki S (2011). Acylation of octaarginine: Implication to the use of intracellular delivery vectors. J Control Release 149: 29-35.
14. Kohane DS (2007) Microparticles and nanoparticles for drug delivery. Biotechnol Bioeng 96: 203-209.
15. Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA (1983) Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm 15: 25-35.
16. Krieger ML, Eckstein N, Schneider V, Koch M, Royer HD, Jaehde U, Bendas G (2010) Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro. Int J Pharm 389: 10-17.
17. Lee JY, Bae KH, Kim JS, Nam YS, Park TG (2011) Intracellular delivery of paclitaxel using oil-free, shell cross-linked HSA-multi-armed PEG nanocapsules. Biomaterials 32: 8635-8644.
18. Lee MK, Lim SJ, Kim CK (2007) Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles. Biomaterials 28: 2137-2146.
19. Li R, Eun JS, Lee MK (2011) Pharmacokinetics and biodistribution of paclitaxel loaded in pegylated solid lipid nanoparticles after intravenous administration. Arch Pharm Res 34: 331-337.
20. Lu.B, Xiong SB,Yang H,Yin XD, Chao RB (2006) Solid lipid nanoparticles of mitoxantrone for local injection against breast cancer and its lymph node metastases. Eur J Pharm Sci 28: 86-95.
21. Müller RH, Mäder K, Gohla S (2000) Solid lipid nanoparticles (SLN) for controlled drug delivery-a review of the state of the art. Eur J Pharm Biopharm 50: 161-177.
22. Mae M, El Andaloussi S, Lundin P, Oskolkov N, Johansson HJ, Guterstam P, Langel U. (2009) A stearylated CPP for delivery of splice correcting oligonucleotides using a non-covalent co-incubation strategy. J Control Release 134: 221-227.
23. Maiolo JR, Ferrer M, Ottinger EA (2005) Effects of cargo molecules on the cellular uptake of arginine-rich cell-penetrating peptides. Biochim Biophys Acta 1712: 161-172.
24. Panchagnula R (1998) Pharmaceutical aspects of paclitaxel. Int J Pharm 172: 1-15.
25. Peppas NA (1985) Analysis of Fickian and non-Fickian drug release from polymers. Pharm Acta Helv 60: 110-111.
26. Qin Y, Chen H, Yuan W, Kuai R, Zhang Q, Xie F, Zhang L, Zhang Z, Liu J, He Q (2011) Liposome formulated with TAT-modified cholesterol for enhancing the brain delivery. Int J Pharm 419: 85-95.
27. Rijt SH, Kostrhunova H, Brabec V, Sadler PJ (2011) Functionalization of osmium arene anticancer complexes with (poly)arginine: effect on cellular uptake, internalization, and cytotoxicity. Bioconjug Chem 22: 218-226.
28. Sawant RR, Torchilin VP (2009) Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivo. Int J Pharm 374: 114-118.
29. Su Z, Niu J, XiaoY, Ping Q, Sun M, Huang A,YouW, Sang X,YuanD(2011) Effect of octreotide-polyethylene glycol(100) monostearate modification on the pharmacokinetics and cellular uptake of nanostructured lipid carrier loaded with hydroxycamptothecine. Mol Pharm 8: 1641-1651.
30. Takayama K,Tadokoro A, Pujals S, Nakase I, Giralt E, Futaki S (2009)Novel system to achieve one-pot modification of cargo molecules with oligoarginine vectors for intracellular delivery. Bioconjug Chem 20: 249-257.
31. Ulbrich K, Michaelis M, Rothweiler F, Knobloch T, Sithisarn P, Cinatl J, Kreuter J (2011) Interaction of folate-conjugated human serum albumin (HSA) nanoparticles with tumour cells. Int J Pharm 406: 128-134.
32. Walrant A, Correia I, Jiao CY, Lequin O, Bent EH, Goasdoue N, Lacombe C, Chassaing G, Sagan S, Alves ID (2011) Different membrane behaviour and cellular uptake of three basic arginine-rich peptides. Biochim Biophys Acta 1808: 382-393.
33. Wender PA, Mitchell DJ, Pattabiraman K, Pelkey ET, Steinman L, Rothbard JB (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. Proc Nat Acad Sci 97: 13003.
34. Wissing S, Kayser O, Muller R (2004) Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev 56: 1257-1272.
35. Wu L, Tang C, Yin C (2010) Folate-mediated solid-liquid lipid nanoparticles for paclitaxel-coated poly(ethylene glycol). Drug Dev Ind Pharm 36: 439-448.
36. Yang SR, Kim SB, Joe CO, Kim JD (2008) Intracellular delivery enhancement of poly(amino acid) drug carriers by oligoarginine conjugation. J Biomed Mater Res A 86: 137-148.
37. You J, Wan F, de Cui F, Sun Y, Du YZ, Hu FQ (2007) Preparation and characteristic of vinorelbine bitartrate-loaded solid lipid nanoparticles. Int J Pharm 343: 270-276.
38. Yuan H, Miao J, Du YZ, You J, Hu FQ, Zeng S (2008) Cellular uptake of solid lipid nanoparticles and cytotoxicity of encapsulated paclitaxel in A549 cancer cells. Int J Pharm 348: 137-145.